Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone Deacetylase Inhibitors In The Treatment Of Cancer: Overview And Perspectives
Giuseppe Giannini, Walter Cabri, Caterina Fattorusso, et al.
Future Medicinal Chemistry (2012) Vol. 4, Iss. 11, pp. 1439-1460
Closed Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host
Vadivel Ganapathy, Muthusamy Thangaraju, Puttur D. Prasad, et al.
Current Opinion in Pharmacology (2013) Vol. 13, Iss. 6, pp. 869-874
Closed Access | Times Cited: 262
Peptidomimetics via modifications of amino acids and peptide bonds
İlker Avan, C. Dennis Hall, Alan R. Katritzky
Chemical Society Reviews (2014) Vol. 43, Iss. 10, pp. 3575-3575
Closed Access | Times Cited: 253
Advances in mass spectrometry-based clinical biomarker discovery
Christopher A. Crutchfield, Stefani N. Thomas, Lori J. Sokoll, et al.
Clinical Proteomics (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 237
Zinc binding groups for histone deacetylase inhibitors
Lei Zhang, Jian Zhang, Qixiao Jiang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2018) Vol. 33, Iss. 1, pp. 714-721
Open Access | Times Cited: 194
Lysine Acetyltransferase GCN5 Potentiates the Growth of Non-small Cell Lung Cancer via Promotion of E2F1, Cyclin D1, and Cyclin E1 Expression
Long Chen, Tingyi Wei, Xiaoxing Si, et al.
Journal of Biological Chemistry (2013) Vol. 288, Iss. 20, pp. 14510-14521
Open Access | Times Cited: 130
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis
Tino Heimburg, Alokta Chakrabarti, Julien Lancelot, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 6, pp. 2423-2435
Open Access | Times Cited: 117
The Search for Potent, Small‐Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
Chiara Zagni, Giuseppe Floresta, Giulia Monciino, et al.
Medicinal Research Reviews (2017) Vol. 37, Iss. 6, pp. 1373-1428
Closed Access | Times Cited: 117
The mutational landscape of chromatin regulatory factors across 4,623 tumor samples
Abel González-Pérez, Alba Jené-Sanz, Núria López-Bigas
Genome biology (2013) Vol. 14, Iss. 9
Open Access | Times Cited: 113
Next-generation of selective histone deacetylase inhibitors
Feifei Yang, Na Zhao, Di Ge, et al.
RSC Advances (2019) Vol. 9, Iss. 34, pp. 19571-19583
Open Access | Times Cited: 112
Modulation of Autophagy by Sorafenib: Effects on Treatment Response
Néstor Prieto‐Domínguez, Raquel Ordóñez, Ana María Cameán Fernández, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 108
Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma
Ting Sun, Hongchun Liu, Liang Ming
Cellular Physiology and Biochemistry (2017) Vol. 44, Iss. 2, pp. 716-727
Open Access | Times Cited: 108
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 620-620
Open Access | Times Cited: 14
Design, synthesis, biological evaluation and molecular docking study of novel chalcone-based hydroxamic acids possessing a central 2, 4-dimethy pyrrole linker as potential HDAC (Histone Deacetylase) inhibitors and anticancer agents
Mozhdeh Yousefian, Maryam Hashemi, Vahid Eskandarpour, et al.
Journal of Molecular Structure (2024) Vol. 1305, pp. 137749-137749
Closed Access | Times Cited: 8
Inhibiting the HIV Integration Process: Past, Present, and the Future
Roberto Di Santo
Journal of Medicinal Chemistry (2013) Vol. 57, Iss. 3, pp. 539-566
Open Access | Times Cited: 89
Towards Selective Inhibition of Histone Deacetylase Isoforms: What Has Been Achieved, Where We Are and What Will Be Next
Florian Thaler, Ciro Mercurio
ChemMedChem (2013) Vol. 9, Iss. 3, pp. 523-536
Closed Access | Times Cited: 87
Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity
Yuhki Yokoyama, Ayaka Matsumoto, Miki Hieda, et al.
Breast Cancer Research (2014) Vol. 16, Iss. 3
Open Access | Times Cited: 83
Mechanisms of action of tasquinimod on the tumour microenvironment
Éric Raymond, Angus Dalgleish, J.‐E. Damber, et al.
Cancer Chemotherapy and Pharmacology (2013) Vol. 73, Iss. 1, pp. 1-8
Open Access | Times Cited: 73
Santacruzamate A, a Potent and Selective Histone Deacetylase Inhibitor from the Panamanian Marine Cyanobacterium cf. Symploca sp.
Christopher Pavlik, Christina Wong, Sophia N. Ononye, et al.
Journal of Natural Products (2013) Vol. 76, Iss. 11, pp. 2026-2033
Open Access | Times Cited: 72
Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model
Md. Suhail Alam†, Michelle Getz, Kasturi Haldar
Science Translational Medicine (2016) Vol. 8, Iss. 326
Closed Access | Times Cited: 68
A Role for Nuclear Actin in HDAC 1 and 2 Regulation
Leonid Serebryannyy, Christina M. Cruz, Primal de Lanerolle
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 61
Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling
Zhi Huang, Wei Zhou, Yongtao Li, et al.
Theranostics (2018) Vol. 8, Iss. 18, pp. 4995-5011
Open Access | Times Cited: 61
Zinc-dependent Deacetylase (HDAC) Inhibitors with Different Zinc Binding Groups
Yan Li, Fang Wang, Xiaoxue Chen, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 3, pp. 223-241
Closed Access | Times Cited: 60
Epigenetic Regulation of Spinal CXCR2 Signaling in Incisional Hypersensitivity in Mice
Yuan Sun, Peyman Sahbaie, De‐Yong Liang, et al.
Anesthesiology (2013) Vol. 119, Iss. 5, pp. 1198-1208
Open Access | Times Cited: 69
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
Rhonda L. Bitting, Daneen Schaeffer, Jason A. Somarelli, et al.
Cancer and Metastasis Reviews (2014) Vol. 33, Iss. 2-3, pp. 441-468
Open Access | Times Cited: 62
Discovery of Inhibitors of Schistosoma mansoni HDAC8 by Combining Homology Modeling, Virtual Screening, and in Vitro Validation
Srinivasaraghavan Kannan, Jelena Melesina, Alexander‐Thomas Hauser, et al.
Journal of Chemical Information and Modeling (2014) Vol. 54, Iss. 10, pp. 3005-3019
Closed Access | Times Cited: 59
Page 1 - Next Page

Scroll to top